Alembic Pharma Q1 Results: Net profit rises 12% YoY to Rs 135 crore

Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 14% YoY to Rs 239 crore, while the EBITDA margins contracted 540 basis points on y-o-y basis to 15.3%